QIA Germany: Xetra


    QIA XE
    Last Updated: Sep 9, 2022 6:30 p.m. CEDT Delayed quote


    0.03 0.06%
    Previous Close
    Advanced Charting
    Volume: 471.36K 65 Day Avg: 498.97K
    94% vs Avg
    45.96 Day Range 46.76
    37.95 52 Week Range 51.56

    Your Watchlists

    Customize 江湖电竞最新版比赛(江湖电竞投注app网站)

    Have Watchlists? Log in to see them here or sign up to get started.

    Chg/Chg %
    No Items in Watchlist

    There are currently no items in this Watchlist.

    No Saved Watchlists

    Create a list of the investments you want to track.

    Uh oh

    Something went wrong while loading Watchlist.

    Recently Viewed Tickers

    No Recent Tickers

    Visit a quote page and your recently viewed tickers will be displayed here.

    QIA Overview

    Key Data

    • Open €46.43
    • Day Range 45.96 - 46.76
    • 52 Week Range 37.95 - 51.56
    • Market Cap €10.51B
    • Shares Outstanding 227.07M
    • Public Float 226.2M
    • Beta 0.32
    • Rev. per Employee €333.07K
    • P/E Ratio 23.56
    • EPS €1.97
    • Yield N/A
    • Dividend N/A
    • Ex-Dividend Date N/A
    • Short Interest N/A
    • % of Float Shorted N/A
    • Average Volume 498.97K


    5 Day
    • 1.64%
    1 Month
    • -4.01%
    3 Month
    • 9.58%
    • -5.25%
    1 Year
    • -1.23%

    Analyst Ratings

    • Sell
    • Under
    • Hold
    • Over
    • Buy
    Number of Ratings 17 Full Ratings

    Recent News

    No Headlines Available

    No Headlines Available

    Qiagen N.V.

    QIAGEN NV is a provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials. The firm assay technologies make these biomolecules visible and ready for analysis. Its bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. The firm automation solutions tie these together in seamless and cost-effective workflows. QIAGEN provides solutions to Molecular Diagnostics (human healthcare) and Life Sciences (academia, pharma R&D, and industrial applications, primarily forensics). The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996, and is headquartered in Venlo, the Netherlands.


    Name Chg % Market Cap
    Sartorius AG Pfd. 1.14% €27.96B
    Stratec SE 0.59% €1.03B
    Lumibird S.A. -1.73% €435.84M